This trial tests an intervention to get ovarian cancer survivors and their at-risk relatives to consider cancer genetic services. It includes foot-in-the-door techniques, tailored/targeted print, website support, and short messages.
- Ovarian Cancer
4 Primary · 7 Secondary · Reporting Duration: Up to 31 months
Awards & Highlights
4 Treatment Groups
Standard Outreach for Close Relatives
1 of 4
Standard Outreach for Survivors
1 of 4
Message-based Outreach Intervention for Close Relatives
1 of 4
Message-based Outreach Intervention (MBI) for Survivors
1 of 4
1240 Total Participants · 4 Treatment Groups
Primary Treatment: Message-based Outreach Intervention for Survivors · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any patient recruitment opportunities with this research endeavor?
"Indubitably, clinicaltrials.gov attests that this experiment is presently searching for participants. This project was initially posted on 24th July 2021 and had its latest update on 18th October 2022. 1 trial site must find 1240 patients to fill the study's quota." - Anonymous Online Contributor
What is the cap on participants in this research?
"Affirmative. Clinicaltrials.gov declares that this medical experiment, which was published on July 24th 2021, is actively enrolling patients. A total of 1240 individuals are necessary for recruitment from 1 location." - Anonymous Online Contributor
What results can be expected from this medical experiment?
"This medical trial will last a maximum of 31 months and seeks to measure the proportion of survivors completing telegenic counselling as its primary outcome. As secondary metrics, researchers are looking at number of return visits to the website by both survivors and relatives; in addition, they plan on measuring duration (in minutes) that survivors spend on said website." - Anonymous Online Contributor